Loading…

Molecular Basis for Differential Sensitivity of α-Conotoxin RegIIA at Rat and Human Neuronal Nicotinic Acetylcholine Receptors

α-Conotoxins, as nicotinic acetylcholine receptor (nAChR) antagonists, are powerful tools for dissecting biologic processes and guiding drug development. The α3β2 and α3β4 nAChR subtypes are expressed in the central and peripheral nervous systems and play a critical role in various pathophysiologica...

Full description

Saved in:
Bibliographic Details
Published in:Molecular pharmacology 2015-12, Vol.88 (6), p.993-1001
Main Authors: Kompella, Shiva N., Cuny, Hartmut, Hung, Andrew, Adams, David J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c384t-451a3b5e7a47f225268f997a94f48d01b15eaa74cd096ae5ed71fffae021a5383
cites cdi_FETCH-LOGICAL-c384t-451a3b5e7a47f225268f997a94f48d01b15eaa74cd096ae5ed71fffae021a5383
container_end_page 1001
container_issue 6
container_start_page 993
container_title Molecular pharmacology
container_volume 88
creator Kompella, Shiva N.
Cuny, Hartmut
Hung, Andrew
Adams, David J.
description α-Conotoxins, as nicotinic acetylcholine receptor (nAChR) antagonists, are powerful tools for dissecting biologic processes and guiding drug development. The α3β2 and α3β4 nAChR subtypes are expressed in the central and peripheral nervous systems and play a critical role in various pathophysiological conditions ranging from nicotine addiction to the development and progression of lung cancer. Here we used the α4/7-conotoxin RegIIA, a disulfide-bonded peptide from the venom of Conus regius, and its analog [N11A,N12A]RegIIA to probe the specific pharmacological properties of rat and human nAChR subtypes. nAChR subtypes were heterologously expressed in Xenopus oocytes and two-electrode voltage clamp recordings used to investigate the effects of the peptides on nAChR activity. RegIIA potently inhibited currents evoked by acetylcholine (ACh) at rat α3β2 (IC50 = 10.7 nM), whereas a 70-fold lower potency was observed at human α3β2 nAChR (IC50 = 704.1 nM). Conversely, there were no species-specific differences in sensitivity to RegIIA at the α3β4 nAChR. Receptor mutagenesis and molecular dynamics studies revealed that this difference can be attributed primarily to a single amino acid change: Glu198 on the rat α3 subunit corresponding to a proline on the human subunit. These findings reveal a novel species- and subunit-specific receptor-antagonist interaction.
doi_str_mv 10.1124/mol.115.100503
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1124_mol_115_100503</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0026895X24032103</els_id><sourcerecordid>26438212</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-451a3b5e7a47f225268f997a94f48d01b15eaa74cd096ae5ed71fffae021a5383</originalsourceid><addsrcrecordid>eNp1kE1OIzEQRi0EgsDMliXyBTq43Ha6exkCM4nEj5SZkWbXctxlMOrYke1EZMWZuAhnwijAjkWpavG9T6VHyCmwIQAX50vf50MOgTHJyj0yAMmhYACwTwaM8VFRN_L_ETmO8ZExELJmh-SIj0RZc-AD8nzje9TrXgV6oaKN1PhAL60xGNAlq3r6B120yW5s2lJv6OtLMfHOJ_9kHZ3j_Ww2pirReR7lOjpdL5Wjt7gO3mX41mqfrLOajjWmba8ffG8dZlDjKvkQf5ADo_qIPz_2Cfn36-rvZFpc3_2eTcbXhS5rkQohQZULiZUSleFc8lFtmqZSjTCi7hgsQKJSldAda0YKJXYVGGMUMg5KlnV5Qoa7Xh18jAFNuwp2qcK2Bda-m2yzyXzIdmcyA2c7YLVeLLH7in-qy4F6F8D89sZiaKO26DR2NqBObeftd91vMGeEfw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Molecular Basis for Differential Sensitivity of α-Conotoxin RegIIA at Rat and Human Neuronal Nicotinic Acetylcholine Receptors</title><source>Full-Text Journals in Chemistry (Open access)</source><creator>Kompella, Shiva N. ; Cuny, Hartmut ; Hung, Andrew ; Adams, David J.</creator><creatorcontrib>Kompella, Shiva N. ; Cuny, Hartmut ; Hung, Andrew ; Adams, David J.</creatorcontrib><description>α-Conotoxins, as nicotinic acetylcholine receptor (nAChR) antagonists, are powerful tools for dissecting biologic processes and guiding drug development. The α3β2 and α3β4 nAChR subtypes are expressed in the central and peripheral nervous systems and play a critical role in various pathophysiological conditions ranging from nicotine addiction to the development and progression of lung cancer. Here we used the α4/7-conotoxin RegIIA, a disulfide-bonded peptide from the venom of Conus regius, and its analog [N11A,N12A]RegIIA to probe the specific pharmacological properties of rat and human nAChR subtypes. nAChR subtypes were heterologously expressed in Xenopus oocytes and two-electrode voltage clamp recordings used to investigate the effects of the peptides on nAChR activity. RegIIA potently inhibited currents evoked by acetylcholine (ACh) at rat α3β2 (IC50 = 10.7 nM), whereas a 70-fold lower potency was observed at human α3β2 nAChR (IC50 = 704.1 nM). Conversely, there were no species-specific differences in sensitivity to RegIIA at the α3β4 nAChR. Receptor mutagenesis and molecular dynamics studies revealed that this difference can be attributed primarily to a single amino acid change: Glu198 on the rat α3 subunit corresponding to a proline on the human subunit. These findings reveal a novel species- and subunit-specific receptor-antagonist interaction.</description><identifier>ISSN: 0026-895X</identifier><identifier>EISSN: 1521-0111</identifier><identifier>DOI: 10.1124/mol.115.100503</identifier><identifier>PMID: 26438212</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Conotoxins - chemistry ; Conotoxins - metabolism ; Dose-Response Relationship, Drug ; Female ; Humans ; Nicotinic Antagonists - chemistry ; Nicotinic Antagonists - metabolism ; Protein Structure, Secondary ; Rats ; Receptors, Nicotinic - chemistry ; Receptors, Nicotinic - metabolism ; Xenopus laevis</subject><ispartof>Molecular pharmacology, 2015-12, Vol.88 (6), p.993-1001</ispartof><rights>2015 American Society for Pharmacology and Experimental Therapeutics</rights><rights>Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-451a3b5e7a47f225268f997a94f48d01b15eaa74cd096ae5ed71fffae021a5383</citedby><cites>FETCH-LOGICAL-c384t-451a3b5e7a47f225268f997a94f48d01b15eaa74cd096ae5ed71fffae021a5383</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26438212$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kompella, Shiva N.</creatorcontrib><creatorcontrib>Cuny, Hartmut</creatorcontrib><creatorcontrib>Hung, Andrew</creatorcontrib><creatorcontrib>Adams, David J.</creatorcontrib><title>Molecular Basis for Differential Sensitivity of α-Conotoxin RegIIA at Rat and Human Neuronal Nicotinic Acetylcholine Receptors</title><title>Molecular pharmacology</title><addtitle>Mol Pharmacol</addtitle><description>α-Conotoxins, as nicotinic acetylcholine receptor (nAChR) antagonists, are powerful tools for dissecting biologic processes and guiding drug development. The α3β2 and α3β4 nAChR subtypes are expressed in the central and peripheral nervous systems and play a critical role in various pathophysiological conditions ranging from nicotine addiction to the development and progression of lung cancer. Here we used the α4/7-conotoxin RegIIA, a disulfide-bonded peptide from the venom of Conus regius, and its analog [N11A,N12A]RegIIA to probe the specific pharmacological properties of rat and human nAChR subtypes. nAChR subtypes were heterologously expressed in Xenopus oocytes and two-electrode voltage clamp recordings used to investigate the effects of the peptides on nAChR activity. RegIIA potently inhibited currents evoked by acetylcholine (ACh) at rat α3β2 (IC50 = 10.7 nM), whereas a 70-fold lower potency was observed at human α3β2 nAChR (IC50 = 704.1 nM). Conversely, there were no species-specific differences in sensitivity to RegIIA at the α3β4 nAChR. Receptor mutagenesis and molecular dynamics studies revealed that this difference can be attributed primarily to a single amino acid change: Glu198 on the rat α3 subunit corresponding to a proline on the human subunit. These findings reveal a novel species- and subunit-specific receptor-antagonist interaction.</description><subject>Animals</subject><subject>Conotoxins - chemistry</subject><subject>Conotoxins - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Female</subject><subject>Humans</subject><subject>Nicotinic Antagonists - chemistry</subject><subject>Nicotinic Antagonists - metabolism</subject><subject>Protein Structure, Secondary</subject><subject>Rats</subject><subject>Receptors, Nicotinic - chemistry</subject><subject>Receptors, Nicotinic - metabolism</subject><subject>Xenopus laevis</subject><issn>0026-895X</issn><issn>1521-0111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp1kE1OIzEQRi0EgsDMliXyBTq43Ha6exkCM4nEj5SZkWbXctxlMOrYke1EZMWZuAhnwijAjkWpavG9T6VHyCmwIQAX50vf50MOgTHJyj0yAMmhYACwTwaM8VFRN_L_ETmO8ZExELJmh-SIj0RZc-AD8nzje9TrXgV6oaKN1PhAL60xGNAlq3r6B120yW5s2lJv6OtLMfHOJ_9kHZ3j_Ww2pirReR7lOjpdL5Wjt7gO3mX41mqfrLOajjWmba8ffG8dZlDjKvkQf5ADo_qIPz_2Cfn36-rvZFpc3_2eTcbXhS5rkQohQZULiZUSleFc8lFtmqZSjTCi7hgsQKJSldAda0YKJXYVGGMUMg5KlnV5Qoa7Xh18jAFNuwp2qcK2Bda-m2yzyXzIdmcyA2c7YLVeLLH7in-qy4F6F8D89sZiaKO26DR2NqBObeftd91vMGeEfw</recordid><startdate>201512</startdate><enddate>201512</enddate><creator>Kompella, Shiva N.</creator><creator>Cuny, Hartmut</creator><creator>Hung, Andrew</creator><creator>Adams, David J.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201512</creationdate><title>Molecular Basis for Differential Sensitivity of α-Conotoxin RegIIA at Rat and Human Neuronal Nicotinic Acetylcholine Receptors</title><author>Kompella, Shiva N. ; Cuny, Hartmut ; Hung, Andrew ; Adams, David J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-451a3b5e7a47f225268f997a94f48d01b15eaa74cd096ae5ed71fffae021a5383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Conotoxins - chemistry</topic><topic>Conotoxins - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Female</topic><topic>Humans</topic><topic>Nicotinic Antagonists - chemistry</topic><topic>Nicotinic Antagonists - metabolism</topic><topic>Protein Structure, Secondary</topic><topic>Rats</topic><topic>Receptors, Nicotinic - chemistry</topic><topic>Receptors, Nicotinic - metabolism</topic><topic>Xenopus laevis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kompella, Shiva N.</creatorcontrib><creatorcontrib>Cuny, Hartmut</creatorcontrib><creatorcontrib>Hung, Andrew</creatorcontrib><creatorcontrib>Adams, David J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Molecular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kompella, Shiva N.</au><au>Cuny, Hartmut</au><au>Hung, Andrew</au><au>Adams, David J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular Basis for Differential Sensitivity of α-Conotoxin RegIIA at Rat and Human Neuronal Nicotinic Acetylcholine Receptors</atitle><jtitle>Molecular pharmacology</jtitle><addtitle>Mol Pharmacol</addtitle><date>2015-12</date><risdate>2015</risdate><volume>88</volume><issue>6</issue><spage>993</spage><epage>1001</epage><pages>993-1001</pages><issn>0026-895X</issn><eissn>1521-0111</eissn><abstract>α-Conotoxins, as nicotinic acetylcholine receptor (nAChR) antagonists, are powerful tools for dissecting biologic processes and guiding drug development. The α3β2 and α3β4 nAChR subtypes are expressed in the central and peripheral nervous systems and play a critical role in various pathophysiological conditions ranging from nicotine addiction to the development and progression of lung cancer. Here we used the α4/7-conotoxin RegIIA, a disulfide-bonded peptide from the venom of Conus regius, and its analog [N11A,N12A]RegIIA to probe the specific pharmacological properties of rat and human nAChR subtypes. nAChR subtypes were heterologously expressed in Xenopus oocytes and two-electrode voltage clamp recordings used to investigate the effects of the peptides on nAChR activity. RegIIA potently inhibited currents evoked by acetylcholine (ACh) at rat α3β2 (IC50 = 10.7 nM), whereas a 70-fold lower potency was observed at human α3β2 nAChR (IC50 = 704.1 nM). Conversely, there were no species-specific differences in sensitivity to RegIIA at the α3β4 nAChR. Receptor mutagenesis and molecular dynamics studies revealed that this difference can be attributed primarily to a single amino acid change: Glu198 on the rat α3 subunit corresponding to a proline on the human subunit. These findings reveal a novel species- and subunit-specific receptor-antagonist interaction.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26438212</pmid><doi>10.1124/mol.115.100503</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0026-895X
ispartof Molecular pharmacology, 2015-12, Vol.88 (6), p.993-1001
issn 0026-895X
1521-0111
language eng
recordid cdi_crossref_primary_10_1124_mol_115_100503
source Full-Text Journals in Chemistry (Open access)
subjects Animals
Conotoxins - chemistry
Conotoxins - metabolism
Dose-Response Relationship, Drug
Female
Humans
Nicotinic Antagonists - chemistry
Nicotinic Antagonists - metabolism
Protein Structure, Secondary
Rats
Receptors, Nicotinic - chemistry
Receptors, Nicotinic - metabolism
Xenopus laevis
title Molecular Basis for Differential Sensitivity of α-Conotoxin RegIIA at Rat and Human Neuronal Nicotinic Acetylcholine Receptors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T13%3A45%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20Basis%20for%20Differential%20Sensitivity%20of%20%CE%B1-Conotoxin%20RegIIA%20at%20Rat%20and%20Human%20Neuronal%20Nicotinic%20Acetylcholine%20Receptors&rft.jtitle=Molecular%20pharmacology&rft.au=Kompella,%20Shiva%20N.&rft.date=2015-12&rft.volume=88&rft.issue=6&rft.spage=993&rft.epage=1001&rft.pages=993-1001&rft.issn=0026-895X&rft.eissn=1521-0111&rft_id=info:doi/10.1124/mol.115.100503&rft_dat=%3Cpubmed_cross%3E26438212%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c384t-451a3b5e7a47f225268f997a94f48d01b15eaa74cd096ae5ed71fffae021a5383%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/26438212&rfr_iscdi=true